Cybin Inc To Carry Out 1-for-38 Reverse Stock Split On September 19th, 2024

Moomoo NewsAug 28 06:35 ET

Cybin Inc. Shareholders Approve Key Decisions

TipRanksAug 27 19:37 ET

Express News | Cybin Inc: Pivotal Trial Designs Incorporate Elements to Address Functional Unblinding

ReutersAug 13 07:30 ET

Express News | Cybin Inc: Expects to Initiate Phase 3 Pivotal Trial in Late Summer 2024

ReutersAug 13 07:30 ET

Cybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive Disorder

BusinesswireAug 13 07:30 ET

Cybin Inc. Advances Neuropsychiatric Drug Development

TipRanksAug 8 08:23 ET